Application 075809

Type
ANDA
Sponsor
DURAMED PHARMS BARR

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001ENPRESSE-21ETHINYL ESTRADIOL; LEVONORGESTRELTABLET;ORAL-210.03MG,0.04MG,0.03MG;0.05MG,0.075MG,0.125MGNoNo
002ENPRESSE-28ETHINYL ESTRADIOL; LEVONORGESTRELTABLET;ORAL-280.03MG,0.04MG,0.03MG;0.05MG,0.075MG,0.125MGNoNo

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A075809-001ENPRESSE-21ETHINYL ESTRADIOL; LEVONORGESTREL0.03MG,0.04MG,0.03MG;0.05MG,0.075MG,0.125MGTABLET / ORAL-212001-07-16
A075809-002ENPRESSE-28ETHINYL ESTRADIOL; LEVONORGESTREL0.03MG,0.04MG,0.03MG;0.05MG,0.075MG,0.125MGTABLET / ORAL-28AB2001-07-16

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 1 matching rows.

Application-product, TE code table
Application-productTE code
A075809-002AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 3 · 86 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-09-14 22:38:342026-08A075809-001ENPRESSE-210.03MG,0.04MG,0.03MG;0.05MG,0.075MG,0.125MGTABLET / ORAL-212001-07-1684e616aacf4f…
2026-09-14 22:38:342026-08A075809-002ENPRESSE-280.03MG,0.04MG,0.03MG;0.05MG,0.075MG,0.125MGTABLET / ORAL-28AB2001-07-1684e616aacf4f…
2026-08-18 06:07:402026-07A075809-001ENPRESSE-210.03MG,0.04MG,0.03MG;0.05MG,0.075MG,0.125MGTABLET / ORAL-212001-07-16caaa826d4ba7…
2026-08-18 06:07:402026-07A075809-002ENPRESSE-280.03MG,0.04MG,0.03MG;0.05MG,0.075MG,0.125MGTABLET / ORAL-28AB2001-07-16caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A075809-001ENPRESSE-210.03MG,0.04MG,0.03MG;0.05MG,0.075MG,0.125MGTABLET / ORAL-212001-07-16011fe1cb6892…
2026-02-19 14:30 UTC2026-02A075809-002ENPRESSE-280.03MG,0.04MG,0.03MG;0.05MG,0.075MG,0.125MGTABLET / ORAL-28AB2001-07-16011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A075809-001ENPRESSE-210.03MG,0.04MG,0.03MG;0.05MG,0.075MG,0.125MGTABLET / ORAL-212001-07-1631067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A075809-002ENPRESSE-280.03MG,0.04MG,0.03MG;0.05MG,0.075MG,0.125MGTABLET / ORAL-28AB2001-07-1631067a03dcf5…
2025-08-23 18:47 UTC2025-08A075809-001ENPRESSE-210.03MG,0.04MG,0.03MG;0.05MG,0.075MG,0.125MGTABLET / ORAL-212001-07-166a471c1ec25d…
2025-08-23 18:47 UTC2025-08A075809-002ENPRESSE-280.03MG,0.04MG,0.03MG;0.05MG,0.075MG,0.125MGTABLET / ORAL-28AB2001-07-166a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A075809-001ENPRESSE-210.03MG,0.04MG,0.03MG;0.05MG,0.075MG,0.125MGTABLET / ORAL-212001-07-16fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A075809-002ENPRESSE-280.03MG,0.04MG,0.03MG;0.05MG,0.075MG,0.125MGTABLET / ORAL-28AB2001-07-16fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A075809-001ENPRESSE-210.03MG,0.04MG,0.03MG;0.05MG,0.075MG,0.125MGTABLET / ORAL-212001-07-16b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A075809-002ENPRESSE-280.03MG,0.04MG,0.03MG;0.05MG,0.075MG,0.125MGTABLET / ORAL-28AB2001-07-16b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A075809-001ENPRESSE-210.03MG,0.04MG,0.03MG;0.05MG,0.075MG,0.125MGTABLET / ORAL-212001-07-1603ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A075809-002ENPRESSE-280.03MG,0.04MG,0.03MG;0.05MG,0.075MG,0.125MGTABLET / ORAL-28AB2001-07-1603ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A075809-001ENPRESSE-210.03MG,0.04MG,0.03MG;0.05MG,0.075MG,0.125MGTABLET / ORAL-212001-07-162680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A075809-002ENPRESSE-280.03MG,0.04MG,0.03MG;0.05MG,0.075MG,0.125MGTABLET / ORAL-28AB2001-07-162680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A075809-001ENPRESSE-210.03MG,0.04MG,0.03MG;0.05MG,0.075MG,0.125MGTABLET / ORAL-212001-07-165bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A075809-002ENPRESSE-280.03MG,0.04MG,0.03MG;0.05MG,0.075MG,0.125MGTABLET / ORAL-28AB2001-07-165bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A075809-001ENPRESSE-210.03MG,0.04MG,0.03MG;0.05MG,0.075MG,0.125MGTABLET / ORAL-212001-07-16d8e5a09893c0…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A075809-002ENPRESSE-280.03MG,0.04MG,0.03MG;0.05MG,0.075MG,0.125MGTABLET / ORAL-28AB2001-07-16d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A075809-001ENPRESSE-210.03MG,0.04MG,0.03MG;0.05MG,0.075MG,0.125MGTABLET / ORAL-212001-07-16d06236e962d9…
2024-10-29 15:01 UTC2024-10A075809-002ENPRESSE-280.03MG,0.04MG,0.03MG;0.05MG,0.075MG,0.125MGTABLET / ORAL-28AB2001-07-16d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A075809-001ENPRESSE-210.03MG,0.04MG,0.03MG;0.05MG,0.075MG,0.125MGTABLET / ORAL-212001-07-1679d66fd596c7…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A075809-002ENPRESSE-280.03MG,0.04MG,0.03MG;0.05MG,0.075MG,0.125MGTABLET / ORAL-28AB2001-07-1679d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A075809-001ENPRESSE-210.03MG,0.04MG,0.03MG;0.05MG,0.075MG,0.125MGTABLET / ORAL-212001-07-16301d65b070ca…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A075809-002ENPRESSE-280.03MG,0.04MG,0.03MG;0.05MG,0.075MG,0.125MGTABLET / ORAL-28AB2001-07-16301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A075809-001ENPRESSE-210.03MG,0.04MG,0.03MG;0.05MG,0.075MG,0.125MGTABLET / ORAL-212001-07-161e350fbaab3a…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A075809-002ENPRESSE-280.03MG,0.04MG,0.03MG;0.05MG,0.075MG,0.125MGTABLET / ORAL-28AB2001-07-161e350fbaab3a…
2024-05-31 18:47 UTC2024-05A075809-001ENPRESSE-210.03MG,0.04MG,0.03MG;0.05MG,0.075MG,0.125MGTABLET / ORAL-212001-07-168072bd15b7f6…
2024-05-31 18:47 UTC2024-05A075809-002ENPRESSE-280.03MG,0.04MG,0.03MG;0.05MG,0.075MG,0.125MGTABLET / ORAL-28AB2001-07-168072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A075809-001ENPRESSE-210.03MG,0.04MG,0.03MG;0.05MG,0.075MG,0.125MGTABLET / ORAL-212001-07-165c6f7cd8ea54…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A075809-002ENPRESSE-280.03MG,0.04MG,0.03MG;0.05MG,0.075MG,0.125MGTABLET / ORAL-28AB2001-07-165c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04A075809-001ENPRESSE-210.03MG,0.04MG,0.03MG;0.05MG,0.075MG,0.125MGTABLET / ORAL-212001-07-165d02ea3f76ae…
2022-04-08 23:34 UTC2022-04A075809-002ENPRESSE-280.03MG,0.04MG,0.03MG;0.05MG,0.075MG,0.125MGTABLET / ORAL-28AB2001-07-165d02ea3f76ae…
2022-04-04 05:41 UTC2022-04A075809-001ENPRESSE-210.03MG,0.04MG,0.03MG;0.05MG,0.075MG,0.125MGTABLET / ORAL-212001-07-164b0b4de00fa7…
2022-04-04 05:41 UTC2022-04A075809-002ENPRESSE-280.03MG,0.04MG,0.03MG;0.05MG,0.075MG,0.125MGTABLET / ORAL-28AB2001-07-164b0b4de00fa7…
2019-12-13 00:20 UTC2019-12A075809-001ENPRESSE-210.03MG,0.04MG,0.03MG;0.05MG,0.075MG,0.125MGTABLET / ORAL-212001-07-1674a2ff9319b5…
2019-12-13 00:20 UTC2019-12A075809-002ENPRESSE-280.03MG,0.04MG,0.03MG;0.05MG,0.075MG,0.125MGTABLET / ORAL-28AB2001-07-1674a2ff9319b5…

Observed Orange Book normalized TE history#

Normalized TE history page 2 of 2 · 43 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2022-09-29 23:25 UTC2022-09A075809-002AB1e64feba35796…
2022-07-09 03:26 UTC · 3 captures of this ZIP2022-07A075809-002AB1cb3db0bc1861…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A075809-002AB1a50c72e98297…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

NDC Listings For This Application#

NDC listings for this application page 1 of 1 · 7 matching rows.

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
0555-9047EnpresseLevonorgestrel and Ethinyl EstradiolTeva Pharmaceuticals USA, Inc.ANDACurrent
0555-9047EnpresseLevonorgestrel and Ethinyl EstradiolTeva Pharmaceuticals USA, Inc.ANDACurrent
0555-9047EnpresseLevonorgestrel and Ethinyl EstradiolTeva Pharmaceuticals USA, Inc.ANDACurrent
0555-9047EnpresseLevonorgestrel and Ethinyl EstradiolTeva Pharmaceuticals USA, Inc.ANDACurrent
0555-9047EnpresseLevonorgestrel and Ethinyl EstradiolTeva Pharmaceuticals USA, Inc.ANDACurrent
0555-9047EnpresseLevonorgestrel and Ethinyl EstradiolTeva Pharmaceuticals USA, Inc.ANDACurrent
21695-855Enpresselevonorgestrel and ethinyl estradiolRebel Distributors CorpANDACurrent